We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The prime focus of the research and development programme, which AstraZeneca said would focus on the benefit and value of innovative medicines for Chinese patients, will be the establishment of an innovation centre China.
The New York-based Global Alliance for TB Drug Development (also known as the TB Alliance) has received $104 million from the Bill and Melinda Gates Foundation to advance a pipeline of new tuberculosis (TB) drugs over the next five years.
New York-based Bristol-Myers Squibb (BMS) and Otsuka Pharmaceutical, headquartered in Japan, have reported that in a recent study, an atypical antipsychotic medicine, aripiprazole, demonstrated significantly greater improvement versus standard-of-care treatment.
The risk of adrenal insufficiency -- the inability of the adrenal gland to produce adequate amounts of cortisol in response to stress -- may increase with the use of oral corticosteroids, according to a study published in the British medical journal Thorax.
Translational Research, a subsidiary of Japan-based Shin Nippon Biomedical, has developed an intranasal formulation of granisetron, an agent with antiemetic efficacy, the company reported.
Synovics Pharmaceuticals, Inc., a company with proprietary technologies for the development of difficult-to-formulate and controlled-release generic and branded oral drugs, today announced that it has closed a financing raising gross proceeds of $21.25 million.
Chemokine Therapeutics Corp, a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders, and vascular diseases, announced today that it has closed a previously announced transaction with Pharmaceutical Product Development, Inc. ("PPD") and re-acquired its licensing rights on its compound CTCE-0214.
GlaxoSmithKline will present new data across a broad, innovative portfolio of experimental cancer medicines and vaccines at the annual American Society of Clinical Oncology (ASCO) meeting in Atlanta starting Friday, June 2nd.